Literature DB >> 21152783

Adverse mucocutaneous reactions related to chemotherapeutic agents: part II.

Paulo Ricardo Criado1, Hebert Roberto Clivati Brandt, Emanuella Rosyane Duarte Moure, Guilherme Luiz Stelko Pereira, Jose Antonio Sanches Júnior.   

Abstract

Events and reactions involving chemotherapy are common in clinical oncology. Chemotherapeutic agents are widely used in therapy. Side effects range from the common to the rare and may be confused with other mucocutaneous manifestations resulting from the oncological treatment. The objective of this paper was to present data on skin reactions to chemotherapy, particularly those cases in which the dermatologist is requested to issue a report and asked to comment on the safety and viability of readministration of a specific drug. The authors describe aspects associated with these events, presenting a detailed analysis of each one of them.

Mesh:

Substances:

Year:  2010        PMID: 21152783     DOI: 10.1590/s0365-05962010000500002

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  4 in total

1.  Risk Factor Analysis and Risk Prediction Model Construction of Pressure Injury in Critically Ill Patients with Cancer: A Retrospective Cohort Study in China.

Authors:  Zhong-Wen Sun; Min-Ru Guo; Li-Zi Yang; Ze-Jun Chen; Zhu-Qing Zhang
Journal:  Med Sci Monit       Date:  2020-09-19

2.  Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital.

Authors:  William Queiroz Guimarães Wiegandt Ceglio; Marina Mattos Rebeis; Marcela Ferreira Santana; Denis Miyashiro; Jade Cury-Martins; José Antônio Sanches
Journal:  An Bras Dermatol       Date:  2021-11-26       Impact factor: 1.896

3.  Evaluation of cutaneous side-effects associated with chemotherapeutic use in oncological patients.

Authors:  Zeynep Utlu; Handan Bilen
Journal:  Postepy Dermatol Alergol       Date:  2021-10-22       Impact factor: 1.837

4.  Persistent docetaxel-induced supravenous erythematous eruption.

Authors:  Karina de Almeida Pinto Fernandes; Paulo Antônio Oldani Felix
Journal:  An Bras Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.